PUBLISHER: Grand View Research | PRODUCT CODE: 1842122
PUBLISHER: Grand View Research | PRODUCT CODE: 1842122
The Middle East artificial intelligence in healthcare market size was valued at USD 435.63 million in 2024 and is projected to reach USD 8390.91 million by 2033, growing at a CAGR of 36.99% from 2025 to 2033. Rapid expansion of digital health infrastructure, growing adoption of telemedicine and remote care, and increasing government investments, coupled with national artificial intelligence (AI) strategies, are factors contributing to market growth.
Healthcare systems across the Middle East are undergoing rapid digitalization, harnessing AI integration. Initiatives such as Abu Dhabi's Malaffi platform, which connects all regional hospitals and clinics via a secure health information exchange, enhance real-time, seamless data sharing. This infrastructure enables AI algorithms to leverage comprehensive, high-quality patient data, significantly improving diagnostic precision, risk stratification, and personalized treatment planning.
In addition, countries such as the UAE and Qatar are investing heavily in smart hospitals, where AI solutions are being embedded into patient care models. The UAE's National Strategy for Artificial Intelligence 2031 and Saudi Vision 2030 prioritize AI integration in healthcare to increase access, efficiency, and quality of care. Investment in AI research centers, talent development like the Mohamed bin Zayed University of Artificial Intelligence, and collaborations with leading U.S. healthcare institutions foster innovation.
Similarly, in April 2025, Abu Dhabi announced it would launch a pioneering AI and healthcare Innovation Hub through a strategic partnership between Abu Dhabi Health Data Services (ADHDS), SRI International (a Silicon Valley-based R&D leader), and VantageBridge Partners (Abu Dhabi private equity). Thus, the expansion of robust digital health ecosystems enables AI adoption at scale, supporting more efficient healthcare delivery.
Moreover, the rapid adoption of telehealth platforms drives market growth further. For instance, SEHA Virtual Hospital is a flagship example of AI-enabled, hub-and-spoke virtual care that augments specialist throughput. In February 2025, Aster DM Healthcare launched myAster, its flagship digital health platform, in Saudi Arabia at LEAP 2025, expanding from its success in the UAE. The AI-powered app integrates telemedicine, online pharmacies, appointment management, chronic disease monitoring, and health record access.
Furthermore, the regional focus on developing biotechnology hubs and precision medicine accelerates demand for AI-powered research, drug discovery, and personalized therapeutics, driving sustained market expansion. For instance, in April 2025, the Institute for Healthier Living Abu Dhabi (IHLAD) and Singleron Biotechnologies launched AD-Omics, a joint venture to advance precision medicine in the Middle East using AI-driven single-cell multi-omics technologies. Thus, the demand for precision medicine and data-driven tailored treatments underscores the accelerated adoption of AI-driven medical devices in this region.
Middle East Artificial Intelligence In Healthcare Market Report Segmentation
This report forecasts revenue growth at the regional and country-level and provides an analysis of industry trends in each of the sub segments from 2021 to 2033. For this study, Grand View Research, Inc. has segmented the Middle East Artificial Intelligence (AI) in healthcare market report based on component, application, technology, end use, and country: